Keyphrases
Healthy Controls
100%
Cerebrospinal Fluid
93%
Psychotic Disorders
65%
Recent-onset
51%
Meta-analysis
48%
Systematic Meta-analysis
46%
Mental Disorders
39%
COVID-19
34%
Denmark
34%
Standardized Mean Difference
27%
Hospitalization
23%
Post-traumatic Headache
18%
Control Subjects
18%
Cerebrospinal Fluid Biomarkers
18%
Prediction Model
18%
Suicide
18%
Unipolar Depression
18%
Machine Learning Approach
18%
Non-COVID-19
17%
Interleukin-8
16%
Neuroinflammation
16%
Psychiatric Hospitalization
16%
Hazard Ratio
15%
Antipsychotics
15%
Psychiatric Inpatients
14%
Interleukin-6
14%
Cognitive Impairment
14%
Placebo
14%
Migraine
13%
Confidence Interval
13%
Relative Risk
12%
Danish Registers
12%
Headache
11%
Migraine-like
11%
Patients with COVID-19
11%
National Cohort Study
11%
Quality of Life
11%
Cell-based
11%
First-episode Psychosis
11%
Medical Treatment
10%
Neurological Disorders
10%
Neuroimmunology
10%
Neural Autoantibodies
10%
Psychosocial Outcomes
10%
Register Study
10%
Risk Factors
10%
Schizophrenia
9%
No Significant Difference
9%
Myocardial Infarction
9%
Treatment Patterns
9%
Neuroscience
Psychosis
65%
Mental Disorder
41%
Meta-Analysis
39%
Leukocyte
29%
Autoantibodies
22%
Cognitive Disorders
21%
Interleukin 6
20%
Headache
19%
Montreal Cognitive Assessment
18%
Migraine
17%
ICD-10
16%
SARS Coronavirus
15%
Protein
14%
Serum Albumin
14%
Blood Brain Barrier
12%
Cell-Based Assays
11%
Placebo
11%
Interleukin 8
11%
Dementia Praecox
10%
Lymphocyte
9%
Cyclic Adenosine Monophosphate
9%
Adenosine Triphosphate Sensitive Potassium Channel
9%
Anti-Inflammatory
9%
Neurological Disorder
9%
Psychopharmacological Treatment
9%
Interleukin 4
9%
Phosphodiesterase III
9%
Automutilation
9%
Psychiatry
9%
Central Nervous System
9%
Major Depressive Disorder
9%
Bipolar Disorder
9%
Myocardial Infarction
9%
Anti-Inflammatory Agent
9%
Magnetic Resonance Imaging
9%
Vagotomy
9%
Body Mass Index
8%
Immunoglobulin G Antibody
7%
Monocyte Chemotactic Protein 1
6%
Macrophage Inflammatory Protein 1
6%
Mood Stabilizer
6%
Typical Antipsychotic
5%
Psychoactive Drug
5%
Interleukin 16
5%
Immunoglobulin G
5%
